Pharmacists can conduct effective consultations with patients

December 06, 2001

Randomised controlled trial of clinical medication review by a pharmacist of elderly patients on repeat prescriptions in general practice BMJ Volume 323, pp 1340-3

Consultations with a trained pharmacist are an effective way of reviewing the drug treatment of older patients, without affecting the workload of general practitioners, concludes a study in this week's BMJ.

Over 1,000 patients aged 65 or over, who were receiving at least one repeat medication, were divided into two groups. The first group was invited to a consultation at which the pharmacist reviewed their medical conditions and current treatment. The second group continued to receive normal care from their general practitioner and primary healthcare staff.

The pharmacist review resulted in more changes to treatment and lower prescribing costs than normal care, without affecting the workload of general practitioners.

Patients seen by the pharmacist were more likely to have changes made to their repeat prescriptions because the pharmacist did a more detailed review than the general practitioner, suggest the authors. This effect could be important because patient compliance has been shown to fall with an increasing number of drugs. Stopping unnecessary drugs may also reduce the risk of adverse effects and interactions, they add.

The small scale of this trial, involving only four practices, in one city and just one pharmacist, limits the generalisability of the results, say the authors. Nevertheless, it shows that significant and clinically important results can be achieved by pharmacists reviewing patients and their treatment.
-end-


BMJ

Related Drugs Articles from Brightsurf:

The danger of Z-drugs for dementia patients
Strong sleeping pills known as 'Z-drugs' are linked with an increased risk of falls, fractures and stroke among people with dementia, according to new research.

Wallflowers could lead to new drugs
Plant-derived chemicals called cardenolides - like digitoxin - have long been used to treat heart disease, and have shown potential as cancer therapies.

Bristol pioneers use of VR for designing new drugs
Researchers at the University of Bristol are pioneering the use of virtual reality (VR) as a tool to design the next generation of drug treatments.

Towards better anti-cancer drugs
The Bayreuth biochemist Dr. Claus-D. Kuhn and his research team have deciphered how the important human oncogene CDK8 is activated in cells of healthy individuals.

Separating drugs with MagLev
The composition of suspicious powders that may contain illicit drugs can be analyzed using a quick and simple method called magneto-Archimedes levitation (MagLev), according to a new study published in the journal Angewandte Chemie.

People are more likely to try drugs for the first time during the summer
American teenagers and adults are more likely to try illegal or recreational drugs for the first time in the summer, a new study shows.

Drugs used to enhance sexual experiences, especially in UK
Combining drugs with sex is common regardless of gender or sexual orientation, reveals new research by UCL and the Global Drug Survey into global trends of substance-linked sex.

Promising new drugs for old pathogen Mtb
UConn researchers are targeting a metabolic pathway, the dihydrofolate reductase pathway, crucial for amino acid synthesis to treat TB infections.

Can psychedelic drugs heal?
Many people think of psychedelics as relics from the hippie generation or something taken by ravers and music festival-goers, but they may one day be used to treat disorders ranging from social anxiety to depression, according to research presented at the annual convention of the American Psychological Association.

New uses for existing antiviral drugs
Broad-spectrum antiviral drugs work against a range of viral diseases, but developing them can be costly and time consuming.

Read More: Drugs News and Drugs Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.